Mediators of sympathetic activation in metabolic syndrome obesity (Q37311415)

19 August 2017

1 reference

title

Mediators of sympathetic activation in metabolic syndrome obesity (English)

1 reference

19 August 2017

0 references

1 reference

Elisabeth A Lambert

3

0 references

author name string

Nora E Straznicky

series ordinal

1

1 reference

PubMed ID

18959829

19 August 2017

Nina Eikelis

series ordinal

2

1 reference

PubMed ID

18959829

19 August 2017

Murray D Esler

series ordinal

4

1 reference

19 August 2017

1 December 2008

1 reference

Current Hypertension Reports

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

440-447

1 reference

19 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-008-0083-1

19 August 2017

0 references

cites work

Ethnic differences in insulinemia and sympathetic tone as links between obesity and blood pressure.

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0083-1

Overweight and hypertension : a 2-way street?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0083-1

Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0083-1

Reflex sympathetic activation induces acute insulin resistance in the human forearm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-008-0083-1

Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation

21 January 2018

1 reference

12 December 2020

Metabolic syndrome is associated with delayed heart rate recovery after exercise

1 reference

12 December 2020

Multiple lipolysis defects in the insulin resistance (metabolic) syndrome

1 reference

12 December 2020

Subcutaneous obesity is not associated with sympathetic neural activation

1 reference

12 December 2020

Sympathetic neural activation in visceral obesity

1 reference

12 December 2020

Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects

1 reference

12 December 2020

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

1 reference

12 December 2020

Interactions between leptin and the human sympathetic nervous system

1 reference

12 December 2020

Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity.

1 reference

12 December 2020

The peripheral sympathetic nervous system in human obesity.

1 reference

12 December 2020

Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese.

1 reference

12 December 2020

Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy

1 reference

12 December 2020

The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea.

1 reference

12 December 2020

The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.

1 reference

12 December 2020

Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure

1 reference

12 December 2020

C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathw

1 reference

12 December 2020

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

1 reference

12 December 2020

Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs

1 reference

12 December 2020

Renal norepinephrine spillover during infusion of nonesterified fatty acids

1 reference

12 December 2020

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

1 reference

12 December 2020

Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals

1 reference

12 December 2020

Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis

1 reference

12 December 2020

Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome

1 reference

12 December 2020

Endurance training increases metabolic rate and norepinephrine appearance rate in older individuals.

1 reference

12 December 2020

What is the contribution of obesity to the metabolic syndrome?

1 reference

12 December 2020

Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension

1 reference

12 December 2020

Gender differences in sympathetic nervous activity: influence of body mass and blood pressure

1 reference

12 December 2020

Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans

1 reference

12 December 2020

Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study.

1 reference

12 December 2020

Raising lipids acutely reduces baroreflex sensitivity

1 reference

12 December 2020

Overweight and sympathetic overactivity in black Americans

1 reference

12 December 2020

Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients.

1 reference

12 December 2020

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

1 reference

12 December 2020

Neural mechanisms in human obesity-related hypertension

1 reference

12 December 2020

Baroreceptor sensitivity is impaired in elderly subjects with metabolic syndrome and insulin resistance

1 reference

12 December 2020

Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension

1 reference

12 December 2020

Is reduced baroreflex gain a component of the metabolic syndrome? Insights from the LINOSA study.

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

How to assess sympathetic activity in humans

1 reference

12 December 2020

Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males

1 reference

12 December 2020

The metabolic syndrome in Australia: prevalence using four definitions

1 reference

12 December 2020

Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects

1 reference

12 December 2020

Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension

1 reference

12 December 2020

Gender differences in muscle sympathetic nerve activity: effect of body fat distribution.

1 reference

12 December 2020

10.1007/S11906-008-0083-1

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18959829